https://doi.org/10.4081/itjm.2018.1067
Pulmonary hypertension: the state of the art
Accepted: 16 July 2018
HTML: 182
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Pulmonary hypertension (PH) is a hemodynamic and pathophysiological condition defined as an increase in mean pulmonary arterial pressure of 25 mmHg or more at rest assessed by right heart catheterisation. It is a progressive disease characterized by high mortality and morbidity. Current PH guidelines suggest that patients with PH should be cared for in dedicated specialist centres, with expertise and resources available to provide high quality care to this fragile population. In this review, we focus on the clinical manifestations, diagnostic algorithm, risk assessment and therapeutic strategies for PH. We also provide an overview of the organisation of PH services in United Kingdom, including designation of expert centres, national audit and steps to ensure the quality and financial viability of PH care.
Downloads
PlumX Metrics
PlumX Metrics provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.
Citations
How to Cite
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.